4709 |
PFO Device Closure for Elderly Patients with Cryptogenic Stroke: Is It Really Clinical Relevant Procedure? |
Jae-Kwan Song |
Apr. 19. 24 |
4708 |
Current Status of Valvular and Structural Heart Disease Intervention in Japan: New Insights from the OCEAN-SHD Family |
Kentaro Hayashida |
Apr. 19. 24 |
4707 |
Moderate AS in HFrEF: Time-to-Treat is Now and Future Expectation from RCTs |
Nicolas Van Mieghem |
Apr. 19. 24 |
4706 |
TAVR-in-TAVR: Planning and Optimizing the Procedure |
Karl Poon |
Apr. 19. 24 |
4705 |
Ultra-Minimalist TAVR: Novel Strategy for a Quick Procedure and Short Hospital Stay |
James Flaherty |
Apr. 19. 24 |
4704 |
No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight from the OCEAN-TAVI Registry |
Shinichi Shirai |
Apr. 19. 24 |
4703 |
EVAR, TEVAR, and Peripheral Interventions: Data from Asan Medical Center |
Taeoh Kim |
Apr. 19. 24 |
4702 |
Preemptive Coil Embolization of IMA/Lumbar A During EVAR Procedure |
Junichi Tazaki |
Apr. 19. 24 |
4701 |
Late Open Conversion Due to Endoleak After EVAR |
Jun Gyo Gwon |
Apr. 19. 24 |
4700 |
The End of the Paclitaxel Scare: Review of the Data and Lessons Learned |
William A. Gray |
Apr. 19. 24 |